| Project/Area Number |
21592038
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Urology
|
|---|
| Research Institution | University of Fukui |
|---|
Principal Investigator |
OYAMA Nobuyuki University of Fukui, 医学部附属病院, 講師 (20223977)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
YOKOYAMA Osamu 福井大学, 医学部, 教授 (90242552)
OKAZAWA Hidehiko 福井大学, 高エネルギー医学研究センター, 教授 (50360813)
|
|---|
| Project Period (FY) |
2009 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Keywords | 泌尿器科学 / PET / 腎細胞癌 / 分子標的治療薬 / 治療効果 |
|---|
| Research Abstract |
We assessed the effectiveness of PET imaging for early evaluation of therapeutic effect of molecular targeting agent for metastatic renal cell carcinoma (mRCC). ^<11>C-acetate (AC) PET showed high uptake in most of the metastatic tumor sites, unless the tumor is less than 1 cm. The sensitivity of FDG PET for these mRCC was lower than AC PET. Our study demonstrated that AC PET may be a possible imaging option for assessing the early therapeutic effect of molecular targeting agent for mRCC.
|
